Overall, this study highlights the potential role of sSMAD4 as a biomarker for early atherosclerosis risk in OSA patients and opens the path for new research on the potential role of SMAD4 as a relevant player in cardiovascular disease. This evidence concerns the gene SMAD4 and cardiovascular disorder.